Our work identifies an unexpected role for NRARP in T-ALL pathogenesis and warrants the search for genomic lesions (or any other alteration—–e.g., transcriptional, epigenetic, or post transcriptional) that may lead to the deregulation of NRARP levels and/or function. The gene discussed is NRARP; the disease is acute lymphoblastic leukemia.